Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis

Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03316781 ·Status: COMPLETED ·Phase: PHASE3

Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00338754 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00237887 ·Status: COMPLETED ·Phase: PHASE3

Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

NCT00735787 ·Status: COMPLETED ·Phase: PHASE4

Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00645814 ·Status: COMPLETED ·Phase: PHASE2

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

NCT00566722 ·Status: COMPLETED ·Phase: PHASE3

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

NCT01970488 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

NCT01401452 ·Status: COMPLETED

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00235820 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00646191 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

NCT06122649 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

NCT06011733 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

NCT06109818 ·Status: COMPLETED ·Phase: PHASE2

Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea

NCT03925441 ·Status: COMPLETED

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

NCT02581345 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation

NCT01644396 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis

NCT01177800 ·Status: COMPLETED ·Phase: PHASE3

Adalimumab in Adult Japanese Subjects With Psoriasis

NCT00647400 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

NCT05531682 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

NCT06842199 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

NCT00927069 ·Status: COMPLETED ·Phase: PHASE3

A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)

NCT00427362 ·Status: COMPLETED ·Phase: PHASE3

A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate

NCT01251614 ·Status: COMPLETED ·Phase: PHASE3

Mechanism of Action Study for Psoriasis

NCT00932113 ·Status: COMPLETED ·Phase: PHASE4

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea

NCT04167462 ·Status: COMPLETED ·Phase: PHASE3